ProCE Banner Activity

ExPEC: A Cause for Concern

Slideset

Learn about the diverse strains of extraintestinal pathogenic Escherichia coli (ExPEC) including pertinent virulence factors and antimicrobial resistance profiles that cause invasive disease.

Released: September 27, 2022

Expiration: September 26, 2023

Share

Faculty

Lilian Abbo

Lilian Abbo, MD, FIDSA

Associate Chief Medical Officer in Infectious Diseases
Jackson Health System
Professor of Infectious Diseases
Department of Medicine & Miami Transplant Institute
University of Miami Miller School of Medicine
Miami, Florida

Julie Ann Justo

Julie Ann Justo, PharmD, MS, FIDSA, BCPS

Clinical Associate Professor

Department of Clinical Pharmacy and Outcomes Sciences

University of South Carolina College of Pharmacy

Infectious Diseases Clinical Pharmacy Specialist

Department of Pharmacy

Prisma Health Richland Hospital

Columbia, South Carolina

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from

Janssen Therapeutics Division of Janssen Products

Program Director Disclosure

Program Director

Lilian Abbo, MD, FIDSA

Associate Chief Medical Officer in Infectious Diseases
Jackson Health System
Professor of Infectious Diseases
Department of Medicine & Miami Transplant Institute
University of Miami Miller School of Medicine
Miami, Florida

Lilian Abbo, MD, FIDSA: consultant/advisor/speaker: Ferring.

Julie Ann Justo, PharmD, MS, FIDSA, BCPS

Clinical Associate Professor

Department of Clinical Pharmacy and Outcomes Sciences

University of South Carolina College of Pharmacy

Infectious Diseases Clinical Pharmacy Specialist

Department of Pharmacy

Prisma Health Richland Hospital

Columbia, South Carolina

Julie Ann Justo, PharmD, MS: consultant/advisor/speaker: bioMérieux, Entasis Therapeutics, Gilead Sciences, Merck, Shionogi, Spero Therapeutics, Therapeutic Research Center; stock ownership: Vaxart.